SCHEMBL23217529

SCHEMBL23217529

NC(CCC(=O)O)c1ccccc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
CNR2 P34972 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
CPA3 P15088 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
SLC15A1 P46059 1/20 0.40
EEF2K O00418 1/20 0.39
GABRP O00591 2/20 0.38
GABRD O14764 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRB1 P18505 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31084151 0.84 CNR2 (0.46) GAACNR2ALDH1A1CYP1A2CYP2D6
SCHEMBL7236109 0.82 EEF2K (0.47) GAACNR2CES2CES1MEN1
SCHEMBL3511352 0.82 EEF2K (0.47) GAACNR2CES2CES1MEN1
SCHEMBL2457680 0.82 EEF2K (0.47) GAACNR2CES2CES1MEN1
SCHEMBL11495829 0.81 CES2 (0.46) GAACNR2ALDH1A1CYP1A2CYP2D6
SCHEMBL21632058 0.80 GABBR2 (0.45) GAACNR2ALDH1A1CYP1A2CYP2D6
SCHEMBL27538066 0.79 MMP2 (0.46) GAACNR2ALDH1A1CYP1A2CYP2D6
SCHEMBL811540 0.79 CYP2D6 (0.42) ALDH1A1CYP1A2CYP2D6TSHRCYP2C19
SCHEMBL11085997 0.79 GAA (0.47) GAACNR2ALDH1A1CYP1A2CYP2D6
SCHEMBL27728236 0.79 CPA3 (0.45) GAACNR2ALDH1A1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021072167-A1 COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES THE SCRIPPS RESEARCH INSTITUTE (US) 2021-04-15 WO disclosed